You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myeloablative chemotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Melanoma, Skin Cancer Trial run by the National Cancer Institute (NCI) (drug, biological, radiation)

Active, not recruiting
  • Metastatic Melanoma
  • Skin Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Medulloblastoma, Neuroectodermal Tumor Trial in Los Angeles, Washington, Gainesville (TTRNA-xALT, TTRNA-DCs)

Active, not recruiting
Has Results
  • Medulloblastoma
  • Neuroectodermal Tumor
  • TTRNA-xALT
  • TTRNA-DCs
  • Los Angeles, California
  • +2 more
Jan 7, 2022

Oral Mucositis Trial in Charlotte (Virgin Coconut Oil)

Not yet recruiting
  • Oral Mucositis
  • Virgin Coconut Oil
  • Charlotte, North Carolina
    Atrium Health Levine Children's Hospital
Aug 5, 2022

Hematologic Malignancies Trial in Lebanon (Stem Cell Transplant, G-CSF, Fludarabine)

Completed
Has Results
  • Hematologic Malignancies
  • Stem Cell Transplant
  • +5 more
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Oct 30, 2020

Leukemia, Myelodysplastic Syndrome, Leukemia, Myeloid, Acute Trial in Nijmegen (anidulafungin 200 mg q48h, anidulafungin 300 mg

Completed
  • Leukemia
  • +2 more
  • anidulafungin 200 mg q48h
  • anidulafungin 300 mg q72h
  • Nijmegen, Netherlands
    Radboud University Nijmegen Medical Centre
Dec 4, 2020

Lymphoma, Non-Hodgkin's, Adult, Lymphoma, Hodgkin's, Adult Trial (FE 203799)

Withdrawn
  • Lymphoma, Non-Hodgkin's, Adult
  • Lymphoma, Hodgkin's, Adult
  • FE 203799
  • (no location specified)
Oct 22, 2020

Leukemia, Lymphoma, MDS Trial (biological, drug, procedure)

Withdrawn
  • Leukemia
  • +2 more
  • filgrastim
  • +4 more
  • (no location specified)
Jul 29, 2020

Metastatic Melanoma Trial in Los Angeles (F5 TCR transgenic cells and MART-1 peptide pulsed dendritic cells, non-myeloablative

Completed
Has Results
  • Metastatic Melanoma
  • F5 TCR transgenic cells and MART-1 peptide pulsed dendritic cells
  • non-myeloablative conditioning chemotherapy
  • Los Angeles, California
    University of California Los Angeles, David Geffen School of Med
Dec 3, 2021

Glioblastoma, Astrocytoma, Pineoblastoma Trial in Chicago (Stem Cell Transplant)

Completed
  • Glioblastoma
  • +4 more
  • Stem Cell Transplant
  • Chicago, Illinois
    Children's Memorial Hospital
Aug 3, 2020

AML, MDS Trial in Belgium, United States (NKR-2)

Completed
  • AML
  • MDS
  • NKR-2
  • Aurora, Colorado
  • +6 more
Apr 30, 2021

Neuroblastoma Trial in Minneapolis (Thiotepa, Cyclophosphamide, Melphalan)

Recruiting
  • Neuroblastoma
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 2, 2022

Acute Myeloid Leukemia, Leukemia, Lymphoblastic, Acute, Leukemia, Bilineage, Acute Trial in Baltimore (Ex vivo expansion of cord

Terminated
Has Results
  • Acute Myeloid Leukemia
  • +3 more
  • Ex vivo expansion of cord blood
  • Baltimore, Maryland
    Johns Hopkins Hospital
Feb 14, 2020

Relapse/Refractory Multiple Myeloma Trial in Belgium, United States (CYAD-211, Endoxan, Fludara)

Recruiting
  • Relapse/Refractory Multiple Myeloma
  • CYAD-211
  • +2 more
  • Tampa, Florida
  • +4 more
Nov 26, 2020

Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Stem cell infusion
  • +5 more
  • Saint Louis, Missouri
    Washington University
Jan 17, 2023

Disseminated Neuroblastoma, Ganglioneuroblastoma, Localized Resectable Neuroblastoma Trial in United States (drug, radiation,

Active, not recruiting
Has Results
  • Disseminated Neuroblastoma
  • +5 more
  • Birmingham, Alabama
  • +22 more
Mar 3, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Belgium, United States (CYAD-02, ENDOXAN, Fludara)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • CYAD-02
  • +2 more
  • Jacksonville, Florida
  • +4 more
Jun 8, 2020

Lymphoma, Non-Hodgkin Trial in United States (Hematopoietic Stem Cell Transplant)

Completed
Has Results
  • Lymphoma, Non-Hodgkin
  • Hematopoietic Stem Cell Transplant
  • Duarte, California
  • +20 more
Dec 7, 2021

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Cleveland (biological, drug, procedure)

Completed
  • Chronic Myeloproliferative Disorders
  • +5 more
  • anti-thymocyte globulin
  • +5 more
  • Cleveland, Ohio
    Case Medical Center, University Hospitals Seidman Cancer Center,
Jul 23, 2020

Sickle Cell Disease Trial in Chicago (Allogeneic Non-Myeloablative Stem Cell Transplantation, Alemtuzumab, Sirolimus)

Recruiting
  • Sickle Cell Disease
  • Allogeneic Non-Myeloablative Stem Cell Transplantation
  • +2 more
  • Chicago, Illinois
    University of Illinois at Chicago
Feb 16, 2022

Myeloablative Allogeneic Hematopoietic Cell Transplantation, Intraoral Photobiomodulation Therapy, Oral Mucositis Trial in

Recruiting
  • Myeloablative Allogeneic Hematopoietic Cell Transplantation
  • +3 more
  • THOR LX2.3 with LED Lollipop
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jun 27, 2022

Sickle Cell Disease, Hemoglobinopathies Trial in Nashville (drug, procedure, radiation)

Active, not recruiting
  • Sickle Cell Disease
  • Hemoglobinopathies
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Dec 20, 2021

B-Cell Lymphoid Malignancies, Hematologic Malignancy, Non-Hodgkin Lymphoma Trial in Miami (Hematopoietic Stem Cells from

Recruiting
  • B-Cell Lymphoid Malignancies
  • +2 more
  • Hematopoietic Stem Cells from HLA-compatible Related
  • Hematopoietic Stem Cells from HLA Unrelated
  • Miami, Florida
    Miami Cancer Institute at Baptist Health of South Florida
May 5, 2022

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, Relapsed, Adult Trial in Nijmegen (UCB-NK cells, IL-2)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia, Relapsed, Adult
  • Nijmegen, Netherlands
    Radboud University Medical Center
Nov 10, 2021

Breast Cancer, Colorectal Cancer, Uveal Melanoma Trial in Orlando, Pittsburgh (TBio-4101, Pembrolizumab)

Recruiting
  • Breast Cancer
  • +2 more
  • Orlando, Florida
  • +1 more
Feb 1, 2023

Hematologic Malignancy Trial in New York (Linac Based VMAT TBI)

Recruiting
  • Hematologic Malignancy
  • Linac Based VMAT TBI
  • New York, New York
    NYU Langone Health
Jan 13, 2022